Works by Liao, Xuhe

Results: 9

Noninvasive PET Imaging of a Ga-68-Radiolabeled RRL-Derived Peptide in Hepatocarcinoma Murine Models.
Published in:
2019
By:
- Huo, Yan;
- Kang, Lei;
- Pang, Xiaoxi;
- Shen, Haoyuan;
- Yan, Ping;
- Zhang, Chunli;
- Liao, Xuhe;
- Chen, Xueqi;
- Wang, Rongfu
Publication type:
journal article
2-[18F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 2, p. 570, doi. 10.1007/s00259-020-04996-4
By:
- Zhao, Yanyan;
- Wu, Caixia;
- Li, Wei;
- Chen, Xueqi;
- Li, Ziao;
- Liao, Xuhe;
- Cui, Yonggang;
- Zhao, Guangyu;
- Liu, Meng;
- Fu, Zhanli
Publication type:
Article
PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1049043
By:
- Yuan Gao;
- Caixia Wu;
- Xueqi Chen;
- Linlin Ma;
- Xi Zhang;
- Jinzhi Chen;
- Xuhe Liao;
- Meng Liu
Publication type:
Article
Cover Image.
Published in:
Journal of Labelled Compounds & Radiopharmaceuticals, 2018, v. 61, n. 11, p. i, doi. 10.1002/jlcr.3683
By:
- Pang, Xiaoxi;
- Liu, Meng;
- Wang, Rongfu;
- Liao, Xuhe;
- Yan, Ping;
- Zhang, Chunli
Publication type:
Article
Radioimmunoimaging and targeting treatment in an immunocompetent murine model of triple‐negative breast cancer using radiolabeled anti–programmed death‐ligand 1 monoclonal antibody.
Published in:
Journal of Labelled Compounds & Radiopharmaceuticals, 2018, v. 61, n. 11, p. 826, doi. 10.1002/jlcr.3650
By:
- Pang, Xiaoxi;
- Liu, Meng;
- Wang, Rongfu;
- Liao, Xuhe;
- Yan, Ping;
- Zhang, Chunli
Publication type:
Article
Diagnostic performance and prognostic value of preoperative 18F-FDG PET/CT in renal cell carcinoma patients with venous tumor thrombus.
Published in:
2022
By:
- Chen, Silu;
- Zhao, Yanyan;
- Tang, Qi;
- Wu, Caixia;
- Wang, Aixiang;
- Ma, Linlin;
- Zhang, Xi;
- Chen, Jinzhi;
- Gao, Yuan;
- Liao, Xuhe;
- Feng, Ninghan;
- Fan, Yan;
- Zhang, Jianhua;
- Li, Xuesong;
- Liu, Meng
Publication type:
journal article
Triazoles as T2‐Exchange Magnetic Resonance Imaging Contrast Agents for the Detection of Nitrilase Activity.
Published in:
Chemistry - A European Journal, 2018, v. 24, n. 56, p. 15013, doi. 10.1002/chem.201802663
By:
- Zhang, Jia;
- Han, Zheng;
- Lu, Jiaqi;
- Li, Yuguo;
- Liao, Xuhe;
- van Zijl, Peter C.;
- Yang, Xing;
- Liu, Guanshu
Publication type:
Article
Potentials of Non-Invasive 18F-FDG PET/CT in Immunotherapy Prediction for Non–Small Cell Lung Cancer.
Published in:
Frontiers in Genetics, 2022, v. 12, p. 1, doi. 10.3389/fgene.2021.810011
By:
- Liao, Xuhe;
- Liu, Meng;
- Wang, Rongfu;
- Zhang, Jianhua
Publication type:
Article
The value on SUV-derived parameters assessed on 18F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer.
Published in:
BMC Medical Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12880-023-01004-7
By:
- Liao, Xuhe;
- Liu, Meng;
- Li, Shanshi;
- Huang, Weiming;
- Guo, Cuiyan;
- Liu, Jia;
- Xiong, Yan;
- Zhang, Jianhua;
- Fan, Yan;
- Wang, Rongfu
Publication type:
Article

Works by Liao, Xuhe

Noninvasive PET Imaging of a Ga-68-Radiolabeled RRL-Derived Peptide in Hepatocarcinoma Murine Models.

2-[18F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma.

PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy.

Cover Image.

Radioimmunoimaging and targeting treatment in an immunocompetent murine model of triple‐negative breast cancer using radiolabeled anti–programmed death‐ligand 1 monoclonal antibody.

Diagnostic performance and prognostic value of preoperative <sup>18</sup>F-FDG PET/CT in renal cell carcinoma patients with venous tumor thrombus.

Triazoles as T<sub>2</sub>‐Exchange Magnetic Resonance Imaging Contrast Agents for the Detection of Nitrilase Activity.

Potentials of Non-Invasive <sup>18</sup>F-FDG PET/CT in Immunotherapy Prediction for Non–Small Cell Lung Cancer.

The value on SUV-derived parameters assessed on <sup>18</sup>F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer.